AAAAAA
Results:
1-13
|
Results: 13
Authors:
Ye, QL
Rahman, MN
Koschinsky, ML
Jia, ZC
Citation: Ql. Ye et al., High-resolution crystal structure of apolipoprotein(a) kringle IV type 7: Insights into ligand binding, PROTEIN SCI, 10(6), 2001, pp. 1124-1129
Authors:
Rahman, MN
Petrounevitch, V
Jia, ZC
Koschinsky, ML
Citation: Mn. Rahman et al., Antifibrinolytic effect of single apo(a) kringle domains: relationship to fibrinogen binding, PROTEIN ENG, 14(6), 2001, pp. 427-438
Authors:
Iliescu, EA
Marcovina, SM
Morton, AR
Koschinsky, ML
Citation: Ea. Iliescu et al., Apolipoprotein(a) phenotype, albumin clearance, and plasma levels of lipoprotein(a) in peritoneal dialysis, NEPHRON, 88(2), 2001, pp. 168-169
Authors:
Becker, L
McLeod, RS
Marcovina, SM
Yao, ZM
Koschinsky, ML
Citation: L. Becker et al., Identification of a critical lysine residue in apolipoprotein B-100 that mediates noncovalent interaction with apolipoprotein(a), J BIOL CHEM, 276(39), 2001, pp. 36155-36162
Authors:
Koschinsky, ML
Boffa, MB
Nesheim, ME
Zinman, B
Hanley, AJG
Harris, SB
Cao, H
Hegele, RA
Citation: Ml. Koschinsky et al., Association of a single nucleotide polymorphism in CPB2 encoding the thrombin-activable fibrinolysis inhibitor (TAFI) with blood pressure, CLIN GENET, 60(5), 2001, pp. 345-349
Authors:
Weisel, JW
Nagaswami, C
Woodhead, JL
Higazi, AAR
Cain, WJ
Marcovina, SM
Koschinsky, ML
Cines, DB
Bdeir, K
Citation: Jw. Weisel et al., The structure of lipoprotein(a) and ligand-induced conformational changes, BIOCHEM, 40(35), 2001, pp. 10424-10435
Authors:
Sangrar, W
Koschinsky, ML
Citation: W. Sangrar et Ml. Koschinsky, Characterization of the interaction of recombinant apolipoprotein(a) with modified fibrinogen surfaces and fibrin clots, BIOC CELL B, 78(4), 2000, pp. 519-525
Authors:
Xia, JZ
May, LF
Koschinsky, ML
Citation: Jz. Xia et al., Characterization of the basis of lipoprotein [a] lysine-binding heterogeneity, J LIPID RES, 41(10), 2000, pp. 1578-1584
Authors:
Marcovina, SM
Koschinsky, ML
Citation: Sm. Marcovina et Ml. Koschinsky, Lipoprotein(a) concentration and apolipoprotein(a) size - A synergistic role in advanced atherosclerosis?, CIRCULATION, 100(11), 1999, pp. 1151-1153
Authors:
Bdeir, K
Cane, W
Canziani, G
Chaiken, I
Weisel, J
Koschinsky, ML
Lawn, RM
Bannerman, PG
Sachais, BS
Kuo, A
Hancock, MA
Tomaszewski, J
Raghunath, PN
Ganz, T
Higazi, AAR
Cines, DB
Citation: K. Bdeir et al., Defensin promotes the binding of lipoprotein(a) to vascular matrix, BLOOD, 94(6), 1999, pp. 2007-2019
Authors:
Boffa, MB
Reid, TS
Joo, E
Nesheim, ME
Koschinsky, ML
Citation: Mb. Boffa et al., Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B), BIOCHEM, 38(20), 1999, pp. 6547-6558
Authors:
Rahman, M
Jia, ZC
Gabel, BR
Marcovina, SM
Koschinsky, ML
Citation: M. Rahman et al., Expression of apolipoprotein(a) kringle IV type 9 in Escherichia coli: demonstration of a specific interaction between kringle IV type 9 and apolipoproteinB-100, PROTEIN ENG, 11(12), 1998, pp. 1249-1256
Authors:
Marcovina, SM
Koschinsky, ML
Citation: Sm. Marcovina et Ml. Koschinsky, Lipoprotein(a) as a risk factor for coronary artery disease, AM J CARD, 82(12A), 1998, pp. 57U-66U
Risultati:
1-13
|